|
Avacta Group PLC - Wetherby, England-based life sciences company developing targeted oncology drugs and diagnostics - Issues 3.8 million new shares of 10 pence each to settle quarterly principal of £2.6 million and interest repayment of £760,000. After settlement of the quarterly repayment, the principal remaining under the convertible bond will be reduced by £2.6 million to £44.2 million. Current stock price: 99.00 pence 12-month change: down 11% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
